Latigo Biotherapeutics, Inc. (LTGO) stock
LTGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026
$13.31−0.45 (-3.27%)
Close on Nov 18, 2026Market cap $882.44MP/E –Yield 0.00%
Latigo Biotherapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Latigo Biotherapeutics's shares outstanding was 38M at Sep 30, 2026.
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 38M | – |
| Q2 FY2026 | Jun 30, 2026 | 1M | – |
| Q3 FY2025 | Sep 30, 2025 | 1M | – |
| Q2 FY2025 | Jun 30, 2025 | 1M | – |
See a number that looks wrong?